• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    NPS Pharmaceuticals, Inc. (NPSP)

    -NasdaqGS
    36.04 Down 0.57(1.56%) Dec 19, 4:00PM EST
    |After Hours : 36.04 Up 0.00 (0.01%) Dec 19, 5:35PM EST
    Add to Portfolio
    Prev Close:36.61
    Open:36.56
    Bid:20.50 x 100
    Ask:N/A
    1y Target Est:37.62
    Beta:0.09
    Earnings Date:Feb 16 - Feb 20 (Est.)
    Day's Range:35.68 - 36.79
    52wk Range:22.11 - 39.68
    Volume:2,290,532
    Avg Vol (3m):1,653,520
    Market Cap:3.85B
    P/E (ttm):3,604.00
    EPS (ttm):0.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NPSPDown 1.56%3.85B
    ABTUp 0.61%69.34B
    BIIBUp 1.97%85.17B

    Key Statistics

    Forward P/E (1 yr):48.05
    P/S (ttm):18.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.02
    Quarterly EPS Est (Dec-14) :0.04
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-16.56

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback